View in EDS

Correction: Enhanced proteasomal activity is essential for long term survival and recurrence of innately radiation resistant residual glioblastoma cells.

Saved in:
Bibliographic Details
Title: Correction: Enhanced proteasomal activity is essential for long term survival and recurrence of innately radiation resistant residual glioblastoma cells.
Authors: Rajendra J; Shilpee Dutt Laboratory, Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Kharghar, Navi Mumbai, India.; Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai, India., Datta KK; Institute of Bioinformatics, International Technology Park, Bangalore, India., Farooqee SBUD; Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre (TMC), Kharghar, Navi Mumbai, India.; Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai, India., Thorat R; Laboratory Animal Facility, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre (TMC), Kharghar, Navi Mumbai, India., Kumar K; Institute of Bioinformatics, International Technology Park, Bangalore, India., Gardi N; Integrated Genomics Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, Maharashtra, India., Kaur E; Shilpee Dutt Laboratory, Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Kharghar, Navi Mumbai, India.; Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai, India., Nair J; Shilpee Dutt Laboratory, Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Kharghar, Navi Mumbai, India.; Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai, India., Salunkhe S; Shilpee Dutt Laboratory, Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Kharghar, Navi Mumbai, India.; Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai, India., Patkar K; Shilpee Dutt Laboratory, Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Kharghar, Navi Mumbai, India., Desai S; Integrated Genomics Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, Maharashtra, India.; Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai, India., Goda JS; Department of Radiation Oncology, Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer, Navi Mumbai, India., Moiyadi A; Department of neurosurgery Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer, Navi Mumbai, India., Dutt A; Integrated Genomics Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, Maharashtra, India.; Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai, India., Venkatraman P; Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre (TMC), Kharghar, Navi Mumbai, India.; Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai, India., Gowda H; Institute of Bioinformatics, International Technology Park, Bangalore, India., Dutt S; Shilpee Dutt Laboratory, Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Kharghar, Navi Mumbai, India.; Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai, India.
Source: Oncotarget [Oncotarget] 2025 Nov 06; Vol. 16, pp. 791-792. Date of Electronic Publication: 2025 Nov 06.
Publication Type: Published Erratum; Journal Article
Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Electronic Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1949-2553
DOI:10.18632/oncotarget.28778